Strategic Review

Description

Many International companies have long histories in the MEA region.

The region over the last decade has undergone significant political, economic and regulatory transformations.

The MEA markets now present many new challenges for all players in the Medical field. Tighter Government health care budgets, longer payment terms…, local sales infrastructures, etc have all significantly changed over the last few years, creating a more complex and competitive business environment

The traditional, historical footprint of many companies no longer brings desired results.

 

TBMedex SAS can conduct a non-biased STRATEGIC REVIEW of your current business in the MEA region.

 

 

Methodology

Milestone 1:

Introduction to customer’s business:

  • Current Export Strategies

  • Products/ Markets / Sales Channels

  • Sensitivities, etc…

Deliverables:

  • Define “countries” scope

  • Define clear operational guidelines for Milestone 2

  • Define clear communication channels and action validation procedures

Milestone 2:

  • Visit the “countries” and audit the existing sales channels

Deliverables:

  • Provide an evaluation report on the sales landscape based on defined scope.

  • Define Milestone 3 based on evaluation report and customer’s defined future strategies

TBMedex SAS

We are a Specialised Medical Consultancy and Regional Distributor with successful track records in commercialising Medical Products into EMEA.

We have a broad functional and Medical Experience. 

We would welcome the opportunity to explore a potential partnership for the region.

  • LinkedIn Social Icon
  • c-facebook
  • Twitter Classic
  • Google Classic

Bussy St Georges, 77600, France.

 

Contact@tbmedex.com

www.tbmedex.com

Legal & Privacy - All Rights Reserved 2020 - TBMedex SAS - Registered in France